Your browser doesn't support javascript.
loading
Dexamethasone inhibits pancreatic tumor growth in preclinical models: Involvement of activating glucocorticoid receptor.
Yao, Ye; Yao, Qing-Yu; Xue, Jun-Sheng; Tian, Xiu-Yun; An, Qi-Ming; Cui, Li-Xuan; Xu, Chang; Su, Hong; Yang, Liang; Feng, Yao-Yao; Hao, Chun-Yi; Zhou, Tian-Yan.
Afiliación
  • Yao Y; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Yao QY; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Xue JS; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Tian XY; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • An QM; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Cui LX; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Xu C; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Su H; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Yang L; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Feng YY; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Hao CY; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China. Electronic address: haochunyi@bjmu.edu.cn.
  • Zhou TY; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Electronic address: tianyanzhou@bjmu.edu.cn.
Toxicol Appl Pharmacol ; 401: 115118, 2020 08 15.
Article en En | MEDLINE | ID: mdl-32619553

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Dexametasona / Receptores de Glucocorticoides / Antineoplásicos Hormonales / Ensayos Antitumor por Modelo de Xenoinjerto / Carga Tumoral Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Toxicol Appl Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Dexametasona / Receptores de Glucocorticoides / Antineoplásicos Hormonales / Ensayos Antitumor por Modelo de Xenoinjerto / Carga Tumoral Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Toxicol Appl Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos